CoChat

The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

Aberrant DNA methylation is the most frequent molecular alteration in acute myeloid leukemia (AML). To identify methylation-silenced genes in AML, we performed microarray analyses in U937 cells exposed to the demethylating agent 5-aza-deoxy-cytidine. Overall, 274 transcripts were significantly induced. Interestingly, C/EBPdelta expression was significantly induced (more than 10-fold) by demethylation whereas expression of all other C/EBP family members remained unchanged. The C/EBPdelta promoter was strongly methylated in different leukemic cell lines and showed signs of a repressed chromatin state. Analyses of the promoter regions of the entire C/EBP family (alpha, beta, gamma, delta, epsilon, zeta) in bone marrow samples from AML patients (n = 80) and controls (n = 15) by mass spectrometry revealed that C/EBPdelta is the most commonly hypermethylated C/EBP gene in AML. Hypermethylation occurred in more than 35% of AML patients at primary diagnosis. A significant correlation (P = .016) was observed between hypermethylation of the C/EBPdelta promoter and low expression of C/EBPdelta in AML patients. C/EBPdelta promoter activity was strongly repressed by methylation in vitro, and transcriptional repression partially depended on MeCP2 activity. C/EBPdelta exhibited growth-inhibitory properties in primary progenitor cells as well as in Flt3-ITD-transformed cells. Taken together, C/EBPdelta is a novel tumor suppressor gene in AML that is silenced by promoter methylation.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2006-08-040147

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 65 references

Cited by

See all 119

Metadata

Authors
Agrawal, S., Hofmann, W.-K., Tidow, N., Ehrich, M., Boom, D. V. D., Koschmieder, S., Berdel, W. E., Serve, H., & Müller-Tidow, C.
Affiliations
  • University of Münster (DE)
  • Department of Oncology and Hematology, University Hospital Benjamin Franklin, Berlin, Germany;
  • Sequenom (United States) (US)
  • Department of Medicine, Hematology and Oncology, University of Münster, Germany;
Venue
Blood
Published
2007-01-18
Volume
109
Issue
9
Pages
3895-3905
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2050847600
Cited by
119
References
63
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 10 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 9 · 2013: 5 · 2012: 11
FWCI
8.04
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Deutsche Krebshilfe
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
C/EBPδ, acute myeloid leukemia, promoter hypermethylation, DNA methylation, tumor suppressor gene silencing, MeCP2, C/EBP family, decitabine, transcriptional repression, FLT3-ITD, leukemia progenitor cells
MeSH terms
Decitabine, Antimetabolites, Antineoplastic, Azacitidine, Female, Humans, Male, Promoter Regions, Genetic, Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic, DNA Methylation, U937 Cells, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Tumor Suppressor Proteins, Chromatin Assembly and Disassembly, CCAAT-Enhancer-Binding Protein-delta, Methyl-CpG-Binding Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. https://app.cochat.ai/papers/10.1182/blood-2006-08-040147
The paper
Agrawal, S., Hofmann, W.-K., Tidow, N., Ehrich, M., Boom, D. V. D., Koschmieder, S., Berdel, W. E., Serve, H., & Müller-Tidow, C. (2007). The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood. https://doi.org/10.1182/blood-2006-08-040147

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.